| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 3.61B | 3.78B | 3.56B | 2.77B | 2.41B |
| Gross Profit | 358.00M | 291.70M | 545.40M | 413.70M | 445.02M |
| EBITDA | 203.90M | 213.90M | 415.30M | 248.50M | 341.00M |
| Net Income | 138.00M | 74.50M | 223.40M | 204.30M | 254.13M |
Balance Sheet | |||||
| Total Assets | 6.38B | 6.04B | 6.09B | 6.02B | 3.84B |
| Cash, Cash Equivalents and Short-Term Investments | 353.70M | 320.30M | 418.30M | 676.80M | 398.71M |
| Total Debt | 596.00M | 597.40M | 605.40M | 645.20M | 197.31M |
| Total Liabilities | 3.05B | 2.81B | 2.77B | 2.77B | 1.45B |
| Stockholders Equity | 3.32B | 3.24B | 3.32B | 3.25B | 2.39B |
Cash Flow | |||||
| Free Cash Flow | 146.40M | 132.10M | -74.90M | 102.30M | 312.79M |
| Operating Cash Flow | 157.40M | 139.00M | -72.10M | 103.90M | 315.85M |
| Investing Cash Flow | -46.20M | 23.10M | 52.50M | -30.30M | -4.12M |
| Financing Cash Flow | -80.80M | -260.10M | -238.90M | 204.50M | -254.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | £3.27B | 9.43 | 10.20% | 6.38% | -6.44% | -0.03% | |
67 Neutral | £3.69B | 17.55 | 2.73% | 4.73% | 28.95% | 43.50% | |
63 Neutral | £2.79B | 28.32 | 2.40% | 8.95% | 13.04% | -54.27% | |
62 Neutral | £2.11B | 13.98 | 4.43% | 2.62% | 13.29% | 7.12% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
59 Neutral | £798.81M | 5.84 | 4.20% | ― | -4.38% | 100.09% | |
58 Neutral | £3.37B | 11.79 | 8.05% | 4.54% | 17.20% | 6.80% |